| Centers | ||
| test | Presude Life Sciences | FDA Oncology Center of Excellence Project Catalyst | 
| sfgd | Presude Lifesciences is an integrated drug discovery and development services organization led by biopharma professionals with global experience.Read more Presude is a research driven company with expertise in medicinal chemistry, custom synthesis and... | Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation | 
| Partnerships | Events | Jobs | 
| GSK and MD Anderson to co-develop new cancer therapeuticsGlaxoSmithkline and MD Anderson Cancer Center entered into a co-development and license agreement to develop antibody based therapeutics to treat cancer. Under this agreement MD Anderson grants exclusive rights to antibodies developed during the... View all The Division of Signal Transduction TherapyA vital asset of the MRC-PPU is the Division of Signal Transduction Therapy (DSTT) which was established in 1998. This division operates as a unique collaboration between scientists in the MRC-PPU (all PIs including Ronald Hay FRS Honorary PI of... View all Pfizer's CTI Establishes New Partnership with UCSFPfizer's Center for Therapeutic Innovation has established a new multi-year research and development partnership with University of California, San Francisco (UCSF). Pfizer will provide $85 million in research and milestone payments over five year... View all | No EVENTS for listing | No Job Posts | 



 
								 
								 
						 		
								 
								
								 
								
								 
								
								 
								
								 
								
								 
								
								